REGN Related Analyst Ratings

Nov 11, 2009 01:34 PM Merriman Curhan Ford Reiterates a 'Buy' on Regeneron (REGN); Raising Target Range

Oct 29, 2009 12:44 PM RBC Downgrades Regeneron Pharmaceuticals (REGN) to Sector Perform

Aug 4, 2009 10:45 AM Merriman Curhan Reiterates Bullish Stance on Regeneron (REGN) Following "Vanilla" Q2

Jul 23, 2009 10:01 AM Needham Comments on "Who's Next" In Biotech After Bristol-Myers (BMY) Buys Medarex (MEDX)

Jul 8, 2009 09:12 AM Piper Jaffray Reiterates an 'Overweight' on Regeneron Pharmaceuticals (REGN); Raises Price Target

May 20, 2009 01:12 PM Barclays Gets Bullish On US Biotechnology Sector (BBH)

May 5, 2009 07:36 AM ThinkEquity Initiates Coverage on Regeneron (REGN) with an Accumulate

May 4, 2009 02:40 PM Credit Suisse Added Regeneron (REGN) to its U.S. Focus List

May 1, 2009 07:49 AM Credit Suisse Upgrades Regeneron (REGN) to Outperform

Mar 30, 2009 07:43 AM Piper Jaffray Upgrades Regeneron Pharmaceuticals (REGN) to Buy

Nov 12, 2008 08:11 AM Piper Jaffray & Co. Initiates Coverage on Regeneron Pharmaceuticals (REGN)

Sep 24, 2008 07:54 AM Baird Initiates Coverage on Regeneron (REGN) with a Neutral

Aug 26, 2008 08:59 AM Boenning & Scattergood Starts Regeneron (REGN) at Market Outperform

Jun 5, 2008 08:04 AM Credit Suisse Downgrades Regeneron (REGN) to Neutral

Jan 22, 2008 11:09 AM Canaccord Adams is recommending 15 names to weather a bad tape: ITRI, HOLX, HANS, ADBE, more...

Nov 2, 2007 10:47 AM Canaccord Adams Starts Regeneron Pharmaceuticals (REGN) at Buy

Jan 31, 2007 09:56 AM Caris & Co Initiates Coverage on Regeneron Pharma (REGN) with an Average Rating

Nov 6, 2006 08:31 AM Credit Suisse Starts Regeneron Pharmaceuticals (REGN) at Outperform

Jul 27, 2006 09:52 AM RBC Capital Starts Regeneron Pharmaceutical (REGN) at Outperform

Apr 24, 2006 08:09 AM Needham Starts Regeneron Phama (REGN) at Buy

Dec 27, 2005 07:29 AM Lehman Brothers upgrades REGN to Overweight

Oct 24, 2005 08:22 AM Morgan Stanley Assumes REGN

Apr 14, 2005 10:41 AM Adams Harkness Re-Launches Coverage of Biotech Sector